日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

PRL3-zumab as an anti-angiogenic therapy in neovascular eye diseases.

PRL3-zumab 作为新生血管性眼病的抗血管生成疗法

Ang Koon Hwee, Thura Min, Tan Queenie Shu Woon, Gupta Abhishek, Kuan Kam Yew, Li Jie, Chia Pei Ling, Qiu Beiying, Hong Jimmy Ming, Guo Ke, Wang Xiaomeng, Su Xinyi, Zeng Qi